Section 1 Reauthorizing the humanitarian device exemption profit incentive
Section 520(m)(6)(A)(iv) of the Federal Food, Drug, and Cosmetic Act (42 U.S.C. 360j(m)(6)(A)(iv)) is amended by striking “2022” and inserting “2027”.
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.
A BILL
Sec. 2 Reauthorizing the pediatric device consortia program
Section 305(e) of the Food and Drug Administration Amendments Act of 2007 (42 U.S.C. 282 note) is amended by striking “fiscal years 2018 through 2022” and inserting “fiscal years 2023 through 2027”.